AI assistant
HERBALIFE LTD. — Director's Dealing 2018
Mar 1, 2018
32337_dirs_2018-03-01_78105e5b-0ce8-4450-8492-2a5fecd53569.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-02-28
Reporting Person: Aspauza Jossie (VP, SAM/CAM)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | M | 2512 | $79.58 | Acquired | 14592 | Direct |
| 2018-02-28 | Common Stock | D | 2171 | $92.10 | Disposed | 12421 | Direct |
| 2018-02-28 | Common Stock | F | 103 | $92.10 | Disposed | 12318 | Direct |
| 2018-02-28 | Common Stock | M | 3752 | $59.98 | Acquired | 16070 | Direct |
| 2018-02-28 | Common Stock | D | 2444 | $92.10 | Disposed | 13626 | Direct |
| 2018-02-28 | Common Stock | F | 393 | $92.10 | Disposed | 13233 | Direct |
| 2018-02-28 | Common Stock | M | 1048 | $62.51 | Acquired | 14281 | Direct |
| 2018-02-28 | Common Stock | D | 712 | $92.10 | Disposed | 13569 | Direct |
| 2018-02-28 | Common Stock | F | 102 | $92.10 | Disposed | 13467 | Direct |
| 2018-02-28 | Common Stock | M | 1102 | $57.19 | Acquired | 14569 | Direct |
| 2018-02-28 | Common Stock | D | 685 | $92.10 | Disposed | 13884 | Direct |
| 2018-02-28 | Common Stock | F | 126 | $92.10 | Disposed | 13758 | Direct |
| 2018-02-28 | Common Stock | S | 9995 | $90.38 | Disposed | 3763 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | Stock Appreciation Rights | $79.58 | M | 2512 | Disposed | 2023-12-19 | Common Stock (2512) | Direct |
| 2018-02-28 | Stock Appreciation Rights | $59.98 | M | 3752 | Disposed | 2024-04-30 | Common Stock (3752) | Direct |
| 2018-02-28 | Stock Appreciation Rights | $62.51 | M | 1048 | Disposed | 2026-05-09 | Common Stock (1048) | Direct |
| 2018-02-28 | Stock Appreciation Rights | $57.19 | M | 1102 | Disposed | 2027-02-27 | Common Stock (1102) | Direct |
Footnotes
F1: The reporting person received 238 shares of common stock upon the net exercise of 2,512 stock appreciation rights ("SARs"). The reporting person forfeited 2,171 shares of common stock underlying the SARs in payment of the exercise price and 103 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F2: The reporting person received 915 shares of common stock upon the net exercise of 3,752 SARs. The reporting person forfeited 2,444 shares of common stock underlying the SARs in payment of the exercise price and 393 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F3: The reporting person received 234 shares of common stock upon the net exercise of 1,048 SARs. The reporting person forfeited 712 shares of common stock underlying the SARs in payment of the exercise price and 102 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F4: The reporting person received 291 shares of common stock upon the net exercise of 1,102 SARs The reporting person forfeited 685 shares of common stock underlying the SARs in payment of the exercise price and 126 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F5: This transaction was executed in multiple trades at prices ranging from $90.11 to $90.65. The price reported reflects the weighted average sale price of $90.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2017, and 20% will vest on May 9, 2018, and the remaining 60% will vest May 9, 2019.
F7: Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested February 27, 2018, 20% will vest February 27, 2019, and the remaining 60% will vest February 27, 2020.